Ben Ash
Ben Ash joined Ardena in 2026 as Chief Financial Officer. He brings more than 20 years of finance leadership experience, predominantly within the pharmaceutical sector, with a strong track record across publicly listed companies in the UK and US as well as privately held organizations.
Most recently, Ben served as Chief Financial Officer at Essential Pharma, a global pharmaceutical company focused on medicines for small, underserved and rare disease patient populations. Prior to this, he held senior finance roles at PTC Therapeutics and Shire.
Ben is a Fellow of the Institute of Chartered Accountants in England and Wales.
Paul Edwards
Paul Edwards joined Ardena in 2026 as Chief People Officer, bringing over 30 years of international Human Resources leadership across complex, science-driven and global organisations.
Paul has extensive experience in shaping people strategy to support organisational growth and transformation, most recently serving in senior HR leadership roles at Catalent Pharma Solutions. In his roles there, he partnered closely with executive and business leaders to strengthen leadership capability, build high-performance cultures and align talent strategy with commercial and operational priorities.
At Ardena, Paul leads the global people agenda with a focus on enhancing leadership capability, talent development, and organisational effectiveness to support the company’s continued expansion and strategic objectives.
Paul holds a joint honours degree in Law and Politics from Durham University in the United Kingdom and is based in New Jersey, USA.
Peter Rose
Peter Rose joined Ardena in 2025 as Chief Information Officer. He brings over 25 years of Information Technology leadership experience spanning multiple industries, including chemicals and pharmaceuticals. Most recently, he was the global head of IT infrastructure and security at Diversey, a global chemical manufacturer, driving technology-enabled transformation, and leading a successful IT migration of the company into the Solenis Group. Before that, he spent a decade at Catalent, where he oversaw all global IT systems supporting quality, analytical, and manufacturing operations. Peter began his career in the Royal Air Force as an aircraft engineer, building a strong technical foundation that continues to shape his practical and results-driven approach to leadership.
Dipesh Patel
Dipesh Patel joined Ardena in 2025 as Chief Quality Officer. He brings over 25 years of experience in the pharmaceutical industry, having held senior leadership roles across CDMOs, virtual biotech companies, and large-scale manufacturing organizations. With an academic background in Chemistry, Biology, and Toxicology, he has built a strong track record in both Quality and Operations, overseeing a broad range of dosage forms and regulatory frameworks. His global experience provides deep insight into diverse regulatory requirements and the practical implementation of robust quality systems across multiple regions. Most recently, Dipesh served as Senior Vice President, Quality, at Accord Healthcare, and prior to that held leadership roles at Catalent as Vice President Quality and Site General Manager. He is also a certified EU Qualified Person (QP).
Jeremie Trochu
Jeremie joined Ardena as Chief Executive Officer in 2024.
He brings an extensive knowledge of the life sciences and CDMO industry, and a proven track record of success in the biopharma sector, with 20 years of experience building and growing businesses globally, expending into new markets, and leading large-scale transformations in both publicly traded and privately held companies.
Jeremie was previously part of the team that helped transform Catalent from a private equity spinoff into a publicly traded global CDMO, and during his tenure there, led the successful acquisition and integration of multiple companies. He holds a Masters degree in Business Administration from EMLyon, France.
Ariane De Ganck, PhD
Since 2019, Ariane has overseen Ardena’s drug product activities, spearheading successful integration and transformation at Ardena Pamplona and expanding the company’s capabilities to include sterile services.
With over a decade of senior management experience in CRO/CDMO sectors, Ariane excels in leading multidisciplinary teams and is dedicated to team development, fostering networks, and maintaining a customer-centric approach. Her leadership has also been instrumental in driving business development initiatives.
Prior to joining Ardena, Ariane made significant contributions to the growth of Biogazelle, a specialized CRO in RNA and DNA biomarker services.
Ariane holds a PhD in biomedical sciences, focusing on proteins and oncology